advertisement
14 Costing studies; pharmacoeconomics (7)
Showing records 1 to 7
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics15159 Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study
Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC
Journal of Glaucoma 2006; 15: 419-425
15068 Screening for glaucoma in Canada: a systematic review of the literature
Einarson TR; Vicente C; Machado M; Covert D; Trope GE; Iskedjian M
Canadian Journal of Ophthalmology 2006; 41: 709-721
14515 Aniridie: Study of the treatments and orientatives costs
Andres Lazaro AM; Bel Prieto E
Ciencia y Tecnologia Pharmaceutica 2006; 16: 47-60
14633 Treating patients with primary open angle glaucoma or ocular hypertension with domestic and imported latanoprost drop: Comparison on efficacy and cost
Ma J-X
International Journal of Ophthalmology 2006; 6: 895-897
15154 On the socio-economic relevance of glaucoma
Grub M; Rohrbach JM
Klinische Monatsblätter für Augenheilkunde 2006; 223: 793-795
14850 Prostaglandin analogues for the treatment of glaucoma and ocular hypertension: A systematic review of economic evidence
Orme M; Boler A
PharmacoEconomics 2006; 24: 743-750
15250 Trends in cost of major eye diseases to medicare, 1991 to 2000
Salm M; Belsky D; Sloan FA
American Journal of Ophthalmology 2006; 142: 976-982
